What tests are required after taking ixazomib?

Ixazomib (Ixazomib), as an oral proteasome inhibitor for the treatment of multiple myeloma, requires a series of tests after taking it to ensure the efficacy and safety of the drug.

1. Routine blood tests are crucial to monitor hematological toxicity during ixazomib treatment. It is recommended to do this once a week, especially in the first few months after starting treatment. Thereafter, the examination interval can be gradually extended to every two weeks or once a month depending on the treatment response and the patient's condition.

2. Liver function tests include serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST) and total bilirubin. Weekly or biweekly administration is recommended to monitor changes in liver function.

3. Renal function tests include serum creatinine, urea nitrogen, etc. Weekly or bi-weekly administration is also recommended to monitor changes in kidney function.

4. Electrocardiogram (ECG) monitors changes in heart function. A baseline electrocardiogram was performed after the start of treatment and then at the end of each session.

5. Imaging examinations such as bone Performed as needed to assess condition and effectiveness of treatment.

6. Immunoglobulin measurement monitors the patient’s immune function. Check immunoglobulin levels regularly.

7. For adverse reactions such as severe gastrointestinal events in patients, it is recommended to monitor serum potassium levels; for patients with skin reactions such as rash, the skin condition needs to be closely monitored and the dosage method should be adjusted.

All examination plans should be formulated based on the doctor's recommendations and the patient's actual condition. Patients should actively cooperate with the doctor's examination arrangements and pay attention to observe their body's reactions in order to adjust the treatment plan in a timely manner. By regularly conducting the above examinations, adverse reactions and complications during ixazomib treatment can be discovered and dealt with in a timely manner, ensuring the safety and efficacy of patient treatment.